Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of Variant ER-alpha Function in Breast Cancer
$484,724Elaine T Alarid · University Of Wisconsin-Madison · R01 · FY2022 · CA
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis
$484,694Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Role of lipid metabolism in CD8+ T cell ferroptosis
$484,536Qing Yi · Methodist Hospital Research Institute · R01 · FY2023 · CA
Role of lipid metabolism in CD8+ T cell ferroptosis
$484,536Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA
Multi-organ culture and pumping systems for ex vivo models of immunity in hybrid tissue-chips
$484,509Rebecca R Pompano · University Of Virginia · R01 · FY2025 · AI
Cellular Senescence and Control of Gene Expression
$484,489Judith Campisi · University Of Calif-Lawrenc Berkeley Lab · R37 · FY2006 · AG
Spatiotemporal Control of T cell Synapse Stabilization and Signaling
$484,347Matthew F Krummel · University Of California, San Francisco · R01 · FY2022 · AI
Spatiotemporal Control of T cell Synapse Stabilization and Signaling
$484,347Matthew F Krummel · University Of California, San Francisco · R01 · FY2021 · AI
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
$484,308Guangwen Ren · Jackson Laboratory · R01 · FY2025 · CA
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
$484,308Guangwen Ren · Jackson Laboratory · R01 · FY2021 · CA
Regulation of ER-beta Signaling in Carcinogenesis
$484,266Rong Li · George Washington University · R01 · FY2021 · CA
Administrative Core
$484,203Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$484,099Wafik S El-Deiry · Brown University · R01 · FY2021 · CA
Development of Angiogenesis Inhibitors
$484,095William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Understanding how elevated triglycerides contribute to triple negative breast cancer growth and metastasis
$483,969Emily Jane Gallagher · Icahn School Of Medicine At Mount Sinai · R37 · FY2025 · CA
Molecular Oncology Training Program
$483,880Dawn Hershman · Columbia University Health Sciences · T32 · FY2024 · CA
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma
$483,859Baoli Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations
$483,852Mark R. Kelley · Indiana University Indianapolis · R01 · FY2022 · CA
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
$483,810Jason B Fleming · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
Project 2: Combined CAR-T cell therapy
$483,710Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
Non-coding RNA regulation of Myeloid Cells
$483,706Jorge Henao-Mejia · University Of Pennsylvania · R01 · FY2024 · CA
Developing new therapeutic strategies against head and neck cancer
$483,667Ratna B Ray · Saint Louis University · R01 · FY2023 · DE
Exploiting a novel regulator of immunometabolism to enhance immunotherapy
$483,665Edward John Usherwood · Dartmouth College · R01 · FY2023 · CA
Improving the translational value of head and neck cancer patient-in-mouse models
$483,592Randall J Kimple · University Of Wisconsin-Madison · R37 · FY2024 · CA
Targeting autophagy to enhance immune checkpoint inhibition
$483,579Ravi K Amaravadi · Wistar Institute · P50 · FY2025 · CA